Our mission is to improve patients’ lives by identifying, developing and commercializing meaningful products to address unmet medical needs. With an international staff composed of experienced sales representatives, health systems and medical education professionals and reimbursement specialists, we have structured our organization to address the unique challenges of patients. Our products reach patients in more than 80 countries.

Defitelio®▼ (defibrotide)
This product is authorised in the non-US countries listed below.

Austria SPC PIL
Belgium - DE SPC PIL
Belgium - FR SPC PIL
Belgium - NL SPC PIL
Bulgaria SPC PIL
Croatia SPC PIL
Cyprus SPC PIL
Czech Republic SPC PIL
Denmark SPC PIL
Estonia SPC PIL
Finland SPC PIL
France SPC PIL
Germany SPC PIL
Greece SPC PIL
Hungary SPC PIL
Iceland SPC PIL
Ireland SPC PIL
Latvia SPC PIL
Lithuania SPC PIL
Luxembourg SPC PIL
Netherlands SPC PIL
Norway SPC PIL
Poland SPC PIL
Portugal SPC PIL
Romania SPC PIL
Slovak Republic SPC PIL
Slovenia SPC PIL
Sweden SPC PIL
United Kingdom SPC PIL
South Korea SPC

If you need to order Defitelio®▼(defibrotide) from one of these countries please click here

Israel SPC

If you need to order Defitelio®▼(defibrotide) from Israel please click here

▼This medicinal product is subject to additional monitoring.

Healthcare professionals are asked to report any suspected adverse reactions via their national reporting system listed in the correspondent SPC. Adverse events should also be reported to Gentium, please send an email to with you name and contact information, and you will be contacted by a Gentium Drug Safety Officer as soon as possible.


This website uses cookies to help us provide you with a more responsive and personalized service. By using this website without changing your cookie settings, you agree to our use of cookies. For more information on how we use cookies and how to delete or block the use of cookies, please see our Privacy Policy. By clicking on I accept you consent to our use of cookies.